ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1290

$844K Total Retail Price of All Prescriptions

Rank: 70 out of 1290

319 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,801 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 478 467 1 17
SIMVASTATIN 470 465 2 1
AMLODIPINE BESYLATE 424 412 3 3
CARVEDILOL 412 375 4 12
OMEPRAZOLE 402 402 5 2
METOPROLOL SUCCINATE 310 306 6 14
DIGOXIN 309 304 7 51
LEVOTHYROXINE SODIUM 299 292 8 4
PLAVIX 273 272 9 32
ATENOLOL 270 264 10 18
CLOPIDOGREL 256 254 11 24
DONEPEZIL HCL 243 243 12 13
METFORMIN HCL 239 229 13 10
FUROSEMIDE 237 225 14 9
NAMENDA 230 230 15 27
AMLODIPINE BESYLATE-BENAZEPRIL 227 223 16 166
LISINOPRIL 203 194 17 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 203 17 92
WARFARIN SODIUM 199 183 19 22
POTASSIUM CHLORIDE 194 194 20 35
NEXIUM 193 192 21 34
PANTOPRAZOLE SODIUM 189 186 22 48
METOPROLOL TARTRATE 186 186 23 7
GABAPENTIN 171 171 24 8
ATORVASTATIN CALCIUM 163 155 25 23
ENALAPRIL MALEATE 156 140 26 62
DIOVAN HCT 147 147 27 112
SYNTHROID 139 136 28 28
ALPRAZOLAM 138 138 29 47
DIOVAN 124 124 30 53
CLONIDINE HCL 123 107 31 66
SERTRALINE HCL 117 114 32 36
ZOLPIDEM TARTRATE 105 105 33 15
LOSARTAN POTASSIUM 103 103 34 19
RANITIDINE HCL 100 100 35 49
JANUMET 93 93 36 217
FOLIC ACID 89 89 37 188
MULTAQ 84 84 38 295
SOTALOL 83 83 39 226
TORSEMIDE 81 81 40 296
PAROXETINE HCL 77 77 41 84
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 41 106
TRICOR 76 72 43 194
ALLOPURINOL 74 72 44 60
DEXILANT 71 70 45 184
GLYBURIDE 71 68 R 45 87
ESCITALOPRAM OXALATE 70 70 47 63
TAMSULOSIN HCL 69 69 48 11
EXFORGE 69 61 48 428
FENOFIBRATE 65 61 50 98
ADVAIR DISKUS 64 64 51 37
MECLIZINE HCL 63 63 52 159
TEMAZEPAM 63 63 52 71
AVODART 62 62 54 69
ALENDRONATE SODIUM 60 60 55 39
ISOSORBIDE MONONITRATE ER 60 60 55 58
BENICAR 55 55 57 205
LYRICA 53 53 58 94
RISPERIDONE 53 53 58 68
AZITHROMYCIN 52 50 60 61
CLONAZEPAM 51 51 61 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.